Clinical trials
Lupus Erythematosus, Systemic trials in Guatemala
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 4 |
| Active, not recruiting | 3 |
| Completed | 2 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| AbbVie | 1 |
| Anthera Pharmaceuticals | 1 |
| AstraZeneca | 1 |
| Eli Lilly and Company | 1 |
| Kezar Life Sciences, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Vor Biopharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 11 |
| Autoimmune Diseases | 3 |
| Lupus Nephritis | 3 |
| Connective Tissue Diseases | 1 |
| Immune System Diseases | 1 |
| Nephritis | 1 |
Trials
Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.